NEW YORK--(BUSINESS WIRE)--Insiders from some of the sector’s most innovative small- and micro-cap biotech companies will discuss their progress with trials and their plans to develop, research, and market important new drugs, diagnostics and delivery technologies at the New York Society of Security Analysts’ 15th Annual Biotech and Specialty Pharmaceuticals Conference on November 30, 2011.
